0001209191-22-039708.txt : 20220628 0001209191-22-039708.hdr.sgml : 20220628 20220628210022 ACCESSION NUMBER: 0001209191-22-039708 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220624 FILED AS OF DATE: 20220628 DATE AS OF CHANGE: 20220628 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BERMAN DENNIS N CENTRAL INDEX KEY: 0001273858 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39676 FILM NUMBER: 221051561 MAIL ADDRESS: STREET 1: 9605 SCRANTON RD STREET 2: STE 240 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Inhibikase Therapeutics, Inc. CENTRAL INDEX KEY: 0001750149 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3350 RIVERWOOD PARKWAY SE, SUITE 1900 CITY: ATLANTA STATE: GA ZIP: 30339 BUSINESS PHONE: 678-392-3419 MAIL ADDRESS: STREET 1: 3350 RIVERWOOD PARKWAY SE, SUITE 1900 CITY: ATLANTA STATE: GA ZIP: 30339 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-06-24 0 0001750149 Inhibikase Therapeutics, Inc. IKT 0001273858 BERMAN DENNIS N C/O 3350 RIVERWOOD PARKWAY SE SUITE 1900 ATLANTA GA 30339 1 0 0 0 Stock Option (right to buy) 0.81 2022-06-24 4 A 0 40000 0.00 A 2029-06-24 Common Stock 40000 40000 I By Molino Ventures, LLC This entire stock option grant will vest 100% in a single tranche on the earlier of June 24, 2023 or the day prior to the next annual meeting of stockholders. /s/ Milton H. Werner, attorney-in-fact 2022-06-28